Today, Prostate Cancer Canada and the Movember Foundation announced $4 million for three leading Canadian researchers on projects surrounding the use of biological markers in the prediction of how well prostate cancer will respond to treatment. The awardees included Dr Kim Chi of our Centre and BC Cancer, for his work using liquid biopsies, a type of blood sample, to determine which treatment will work best for men with advanced prostate cancer that has spread outside the prostate and is currently incurable. Click here for more details at Prostate Cancer Canada's website (opens in new tab).